 | • レポートコード：GIR-107A15080 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ラニビズマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ラニビズマブの種類別市場規模（使い捨てプレフィルドシリンジ、使い捨てガラスバイアル）、用途別市場規模（wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ラニビズマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Genentech、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：使い捨てプレフィルドシリンジ、使い捨てガラスバイアル ・用途別分析2016年-2026年：wAMD、糖尿病性網膜症（DR）、糖尿病性黄斑浮腫（DME）、mCNV、RVO ・ラニビズマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ラニビズマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ラニビズマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ラニビズマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ラニビズマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Ranibizumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Ranibizumab size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Ranibizumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Ranibizumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single-use prefilled syringe
Single-use glass vial
Market segment by Application, can be divided into
wAMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
Market segment by players, this report covers
Genentech
Novartis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Ranibizumab
1.2 Classification of Ranibizumab by Type
1.2.1 Overview: Global Ranibizumab Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Ranibizumab Revenue Market Share by Type in 2020
1.2.3 Single-use prefilled syringe
1.2.4 Single-use glass vial
1.3 Global Ranibizumab Market by Application
1.3.1 Overview: Global Ranibizumab Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 wAMD
1.3.3 Diabetic Retinopathy (DR)
1.3.4 Diabetic Macular Edema (DME)
1.3.5 mCNV
1.3.6 RVO
1.4 Global Ranibizumab Market Size & Forecast
1.5 Global Ranibizumab Market Size and Forecast by Region
1.5.1 Global Ranibizumab Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Ranibizumab Market Size by Region, (2016-2021)
1.5.3 North America Ranibizumab Market Size and Prospect (2016-2026)
1.5.4 Europe Ranibizumab Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Ranibizumab Market Size and Prospect (2016-2026)
1.5.6 South America Ranibizumab Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Ranibizumab Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Ranibizumab Market Drivers
1.6.2 Ranibizumab Market Restraints
1.6.3 Ranibizumab Trends Analysis
2 Company Profiles
2.1 Genentech
2.1.1 Genentech Details
2.1.2 Genentech Major Business
2.1.3 Genentech Ranibizumab Product and Solutions
2.1.4 Genentech Ranibizumab Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Genentech Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Ranibizumab Product and Solutions
2.2.4 Novartis Ranibizumab Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Ranibizumab Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Ranibizumab Players Market Share
3.2.2 Top 10 Ranibizumab Players Market Share
3.2.3 Market Competition Trend
3.3 Ranibizumab Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Ranibizumab Revenue and Market Share by Type (2016-2021)
4.2 Global Ranibizumab Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Ranibizumab Revenue Market Share by Application (2016-2021)
5.2 Ranibizumab Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Ranibizumab Revenue by Type (2016-2026)
6.2 North America Ranibizumab Revenue by Application (2016-2026)
6.3 North America Ranibizumab Market Size by Country
6.3.1 North America Ranibizumab Revenue by Country (2016-2026)
6.3.2 United States Ranibizumab Market Size and Forecast (2016-2026)
6.3.3 Canada Ranibizumab Market Size and Forecast (2016-2026)
6.3.4 Mexico Ranibizumab Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Ranibizumab Revenue by Type (2016-2026)
7.2 Europe Ranibizumab Revenue by Application (2016-2026)
7.3 Europe Ranibizumab Market Size by Country
7.3.1 Europe Ranibizumab Revenue by Country (2016-2026)
7.3.2 Germany Ranibizumab Market Size and Forecast (2016-2026)
7.3.3 France Ranibizumab Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Ranibizumab Market Size and Forecast (2016-2026)
7.3.5 Russia Ranibizumab Market Size and Forecast (2016-2026)
7.3.6 Italy Ranibizumab Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Ranibizumab Revenue by Type (2016-2026)
8.2 Asia-Pacific Ranibizumab Revenue by Application (2016-2026)
8.3 Asia-Pacific Ranibizumab Market Size by Region
8.3.1 Asia-Pacific Ranibizumab Revenue by Region (2016-2026)
8.3.2 China Ranibizumab Market Size and Forecast (2016-2026)
8.3.3 Japan Ranibizumab Market Size and Forecast (2016-2026)
8.3.4 South Korea Ranibizumab Market Size and Forecast (2016-2026)
8.3.5 India Ranibizumab Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Ranibizumab Market Size and Forecast (2016-2026)
8.3.7 Australia Ranibizumab Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Ranibizumab Revenue by Type (2016-2026)
9.2 South America Ranibizumab Revenue by Application (2016-2026)
9.3 South America Ranibizumab Market Size by Country
9.3.1 South America Ranibizumab Revenue by Country (2016-2026)
9.3.2 Brazil Ranibizumab Market Size and Forecast (2016-2026)
9.3.3 Argentina Ranibizumab Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Ranibizumab Revenue by Type (2016-2026)
10.2 Middle East & Africa Ranibizumab Revenue by Application (2016-2026)
10.3 Middle East & Africa Ranibizumab Market Size by Country
10.3.1 Middle East & Africa Ranibizumab Revenue by Country (2016-2026)
10.3.2 Turkey Ranibizumab Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Ranibizumab Market Size and Forecast (2016-2026)
10.3.4 UAE Ranibizumab Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Ranibizumab Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Ranibizumab Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Ranibizumab Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Ranibizumab Revenue (USD Million) by Region (2016-2021)
Table 5. Global Ranibizumab Revenue Market Share by Region (2021-2026)
Table 6. Genentech Corporate Information, Head Office, and Major Competitors
Table 7. Genentech Major Business
Table 8. Genentech Ranibizumab Product and Solutions
Table 9. Genentech Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Ranibizumab Product and Solutions
Table 13. Novartis Ranibizumab Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Global Ranibizumab Revenue (USD Million) by Players (2019-2021)
Table 15. Global Ranibizumab Revenue Share by Players (2019-2021)
Table 16. Breakdown of Ranibizumab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 17. Ranibizumab Players Head Office, Products and Services Provided
Table 18. Ranibizumab Mergers & Acquisitions in the Past Five Years
Table 19. Ranibizumab New Entrants and Expansion Plans
Table 20. Global Ranibizumab Revenue (USD Million) by Type (2016-2021)
Table 21. Global Ranibizumab Revenue Share by Type (2016-2021)
Table 22. Global Ranibizumab Revenue Forecast by Type (2021-2026)
Table 23. Global Ranibizumab Revenue by Application (2016-2021)
Table 24. Global Ranibizumab Revenue Forecast by Application (2021-2026)
Table 25. North America Ranibizumab Revenue by Type (2016-2021) & (USD Million)
Table 26. North America Ranibizumab Revenue by Type (2021-2026) & (USD Million)
Table 27. North America Ranibizumab Revenue by Application (2016-2021) & (USD Million)
Table 28. North America Ranibizumab Revenue by Application (2021-2026) & (USD Million)
Table 29. North America Ranibizumab Revenue by Country (2016-2021) & (USD Million)
Table 30. North America Ranibizumab Revenue by Country (2021-2026) & (USD Million)
Table 31. Europe Ranibizumab Revenue by Type (2016-2021) & (USD Million)
Table 32. Europe Ranibizumab Revenue by Type (2021-2026) & (USD Million)
Table 33. Europe Ranibizumab Revenue by Application (2016-2021) & (USD Million)
Table 34. Europe Ranibizumab Revenue by Application (2021-2026) & (USD Million)
Table 35. Europe Ranibizumab Revenue by Country (2016-2021) & (USD Million)
Table 36. Europe Ranibizumab Revenue by Country (2021-2026) & (USD Million)
Table 37. Asia-Pacific Ranibizumab Revenue by Type (2016-2021) & (USD Million)
Table 38. Asia-Pacific Ranibizumab Revenue by Type (2021-2026) & (USD Million)
Table 39. Asia-Pacific Ranibizumab Revenue by Application (2016-2021) & (USD Million)
Table 40. Asia-Pacific Ranibizumab Revenue by Application (2021-2026) & (USD Million)
Table 41. Asia-Pacific Ranibizumab Revenue by Region (2016-2021) & (USD Million)
Table 42. Asia-Pacific Ranibizumab Revenue by Region (2021-2026) & (USD Million)
Table 43. South America Ranibizumab Revenue by Type (2016-2021) & (USD Million)
Table 44. South America Ranibizumab Revenue by Type (2021-2026) & (USD Million)
Table 45. South America Ranibizumab Revenue by Application (2016-2021) & (USD Million)
Table 46. South America Ranibizumab Revenue by Application (2021-2026) & (USD Million)
Table 47. South America Ranibizumab Revenue by Country (2016-2021) & (USD Million)
Table 48. South America Ranibizumab Revenue by Country (2021-2026) & (USD Million)
Table 49. Middle East & Africa Ranibizumab Revenue by Type (2016-2021) & (USD Million)
Table 50. Middle East & Africa Ranibizumab Revenue by Type (2021-2026) & (USD Million)
Table 51. Middle East & Africa Ranibizumab Revenue by Application (2016-2021) & (USD Million)
Table 52. Middle East & Africa Ranibizumab Revenue by Application (2021-2026) & (USD Million)
Table 53. Middle East & Africa Ranibizumab Revenue by Country (2016-2021) & (USD Million)
Table 54. Middle East & Africa Ranibizumab Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Ranibizumab Picture
Figure 2. Global Ranibizumab Revenue Market Share by Type in 2020
Figure 3. Single-use prefilled syringe
Figure 4. Single-use glass vial
Figure 5. Ranibizumab Revenue Market Share by Application in 2020
Figure 6. wAMD Picture
Figure 7. Diabetic Retinopathy (DR) Picture
Figure 8. Diabetic Macular Edema (DME) Picture
Figure 9. mCNV Picture
Figure 10. RVO Picture
Figure 11. Global Ranibizumab Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Ranibizumab Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Ranibizumab Revenue Market Share by Region (2016-2026)
Figure 14. Global Ranibizumab Revenue Market Share by Region in 2020
Figure 15. North America Ranibizumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Ranibizumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Ranibizumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Ranibizumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Ranibizumab Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Ranibizumab Market Drivers
Figure 21. Ranibizumab Market Restraints
Figure 22. Ranibizumab Market Trends
Figure 23. Genentech Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. Global Ranibizumab Revenue Share by Players in 2020
Figure 26. Ranibizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players Ranibizumab Revenue Market Share in 2020
Figure 28. Global Top 10 Players Ranibizumab Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global Ranibizumab Revenue Share by Type in 2020
Figure 31. Global Ranibizumab Market Share Forecast by Type (2021-2026)
Figure 32. Global Ranibizumab Revenue Share by Application in 2020
Figure 33. Global Ranibizumab Market Share Forecast by Application (2021-2026)
Figure 34. North America Ranibizumab Sales Market Share by Type (2016-2026)
Figure 35. North America Ranibizumab Sales Market Share by Application (2016-2026)
Figure 36. North America Ranibizumab Revenue Market Share by Country (2016-2026)
Figure 37. United States Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe Ranibizumab Sales Market Share by Type (2016-2026)
Figure 41. Europe Ranibizumab Sales Market Share by Application (2016-2026)
Figure 42. Europe Ranibizumab Revenue Market Share by Country (2016-2026)
Figure 43. Germany Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Ranibizumab Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific Ranibizumab Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific Ranibizumab Revenue Market Share by Region (2016-2026)
Figure 51. China Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America Ranibizumab Sales Market Share by Type (2016-2026)
Figure 58. South America Ranibizumab Sales Market Share by Application (2016-2026)
Figure 59. South America Ranibizumab Revenue Market Share by Country (2016-2026)
Figure 60. Brazil Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa Ranibizumab Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa Ranibizumab Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa Ranibizumab Revenue Market Share by Country (2016-2026)
Figure 65. Turkey Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE Ranibizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source
世界の増殖性糖尿病性網膜症治療市場 2021：企業別、地域別、種類・用途別 The Proliferative Diabetic Retinopathy Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…- 世界のプレフィルド注射器バレル市場 2021：企業別、地域別、種類・用途別 The Prefilled Syringe Barrels market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界の網膜硝子体用プレフィルドシリコーンオイルシリンジ市場 2021：企業別、地域別、種類・用途別 The Vitreo Retinal Prefilled Silicone Oil Syringe market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界のプレフィルド注射器充填機市場 2021：企業別、地域別、種類・用途別 The Prefilled Syringe Filling Machines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の糖尿病性ケトアシドーシス治療市場 2021：企業別、地域別、種類・用途別 The Diabetic Ketoacidosis Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…